Katherine Ellingson1, Kelly McCormick, Ronda Sinkowitz-Cochran, Tiffanee Woodard, John Jernigan, Arjun Srinivasan, Kimberly Rask. 1. Katherine Ellingson, Kelly McCormick, Ronda Sinkowitz-Cochran, Tiffanee Woodard, John Jernigan, and Arjun Srinivasan are with the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta GA. Kimberly Rask is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta.
Abstract
OBJECTIVES: We evaluated capacity built and outcomes achieved from September 1, 2009, to December 31, 2011, by 51 health departments (HDs) funded through the American Recovery and Reinvestment Act (ARRA) for health care-associated infection (HAI) program development. METHODS: We defined capacity for HAI prevention at HDs by 25 indicators of activity in 6 categories: staffing, partnerships, training, technical assistance, surveillance, and prevention. We assessed state-level infection outcomes by modeling quarterly standardized infection ratios (SIRs) for device- and procedure-associated infections with longitudinal regression models. RESULTS: With ARRA funds, HDs created 188 HAI-related positions and supported 1042 training programs, 53 surveillance data validation projects, and 60 prevention collaboratives. All states demonstrated significant declines in central line-associated bloodstream and surgical site infections. States that implemented ARRA-funded catheter-associated urinary tract infection prevention collaboratives showed significantly greater SIR reductions over time than states that did not (P = .02). CONCLUSIONS: ARRA-HAI funding substantially improved HD capacity to reduce HAIs not targeted by other national efforts, suggesting that HDs can play a critical role in addressing emerging or neglected HAIs.
OBJECTIVES: We evaluated capacity built and outcomes achieved from September 1, 2009, to December 31, 2011, by 51 health departments (HDs) funded through the American Recovery and Reinvestment Act (ARRA) for health care-associated infection (HAI) program development. METHODS: We defined capacity for HAI prevention at HDs by 25 indicators of activity in 6 categories: staffing, partnerships, training, technical assistance, surveillance, and prevention. We assessed state-level infection outcomes by modeling quarterly standardized infection ratios (SIRs) for device- and procedure-associated infections with longitudinal regression models. RESULTS: With ARRA funds, HDs created 188 HAI-related positions and supported 1042 training programs, 53 surveillance data validation projects, and 60 prevention collaboratives. All states demonstrated significant declines in central line-associated bloodstream and surgical site infections. States that implemented ARRA-funded catheter-associated urinary tract infection prevention collaboratives showed significantly greater SIR reductions over time than states that did not (P = .02). CONCLUSIONS: ARRA-HAI funding substantially improved HD capacity to reduce HAIs not targeted by other national efforts, suggesting that HDs can play a critical role in addressing emerging or neglected HAIs.
Authors: Peter Pronovost; Dale Needham; Sean Berenholtz; David Sinopoli; Haitao Chu; Sara Cosgrove; Bryan Sexton; Robert Hyzy; Robert Welsh; Gary Roth; Joseph Bander; John Kepros; Christine Goeschel Journal: N Engl J Med Date: 2006-12-28 Impact factor: 91.245
Authors: Grace M Lee; Ken Kleinman; Stephen B Soumerai; Alison Tse; David Cole; Scott K Fridkin; Teresa Horan; Richard Platt; Charlene Gay; William Kassler; Donald A Goldmann; John Jernigan; Ashish K Jha Journal: N Engl J Med Date: 2012-10-11 Impact factor: 91.245
Authors: Rajiv Jain; Stephen M Kralovic; Martin E Evans; Meredith Ambrose; Loretta A Simbartl; D Scott Obrosky; Marta L Render; Ron W Freyberg; John A Jernigan; Robert R Muder; LaToya J Miller; Gary A Roselle Journal: N Engl J Med Date: 2011-04-14 Impact factor: 91.245
Authors: Darren R Linkin; Neil O Fishman; Judy A Shea; Wei Yang; Mark S Cary; Ebbing Lautenbach Journal: Infect Control Hosp Epidemiol Date: 2013-06-25 Impact factor: 3.254
Authors: Allison Lipitz-Snyderman; Donald Steinwachs; Dale M Needham; Elizabeth Colantuoni; Laura L Morlock; Peter J Pronovost Journal: BMJ Date: 2011-01-28
Authors: Patricia W Stone; Monika Pogorzelska-Maziarz; Julie Reagan; Jacqueline A Merrill; Brad Sperber; Catherine Cairns; Matthew Penn; Tara Ramanathan; Elizabeth Mothershed; Elizabeth Skillen Journal: BMJ Qual Saf Date: 2015-06-04 Impact factor: 7.035
Authors: Melanie D Whittington; Cathy J Bradley; Adam J Atherly; Jonathan D Campbell; Richard C Lindrooth Journal: Am J Public Health Date: 2017-09-21 Impact factor: 9.308
Authors: H R Martínez-Morel; J Sanchez-Payá; P García-Shimizu; J L Mendoza-García; I Tenza-Iglesias; J C Rodríguez-Díaz; E Merino-DE-Lucas; A Nolasco Journal: Epidemiol Infect Date: 2016-01-13 Impact factor: 4.434